Search results for "FIBRILLATION"

showing 10 items of 509 documents

Abstract WP201: Stroke Patients With Atrial Fibrillation Detected by 72 hour- versus Prolonged ECG-monitoring

2018

Background: Detecting concealed paroxysmal atrial fibrillation (pAF) is a major focus in the workup of ischemic-stroke-patients. The minimal ECG-monitoring for stroke patients was recently expanded from 24 to 72 hours. However, it has been shown that even more prolonged monitoring reveals further pAF-cases. Our aim was to determine, whether known predictors for underlying pAF differ between stroke patients with AF that occurs on shorter (72h) or more prolonged ECG-monitoring (>72h). Methods: The Find-AF RANDOMISED -trial (NCT01855035) evaluated 3x10-day Holter-ECG vs. standard-care in patients > 60 years with acute ischemic strokes with the primary endpoint of novel pAF after 6 month…

Advanced and Specialized Nursingmedicine.medical_specialtyStroke patientmedicine.diagnostic_testbusiness.industrymedicine.drug_classParoxysmal atrial fibrillationAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseEcg monitoring03 medical and health sciences0302 clinical medicineInternal medicinemedicineNatriuretic peptideCardiologycardiovascular diseasesNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessElectrocardiographyStroke030217 neurology & neurosurgeryStroke
researchProduct

2019

Background and Purpose— Prevalence of atrial fibrillation (AF) is increasing, but the impact on overall burden of stroke is uncertain, as is the proportion that could be attributed to under anticoagulation. We did a population-based study of AF-associated stroke and a systematic review of time trends in other stroke incidence studies and of rates of premorbid anticoagulation. Methods— The proportion of incident strokes with associated AF was determined in the OXVASC (Oxford Vascular Study; 2002–2017) and in other prospective, population-based stroke incidence studies published before December 2017. Proportions were pooled by Mantel Haenszel methods, and the pooled percentage of cases with …

Advanced and Specialized Nursingmedicine.medical_specialtyeducation.field_of_studyTime trendsbusiness.industryIncidence (epidemiology)PopulationAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseCochran–Mantel–Haenszel statistics03 medical and health sciences0302 clinical medicineInternal medicinemedicinePopulation studyNeurology (clinical)Cardiology and Cardiovascular MedicineeducationbusinessProspective cohort studyStroke030217 neurology & neurosurgeryStroke
researchProduct

Abstract 124: How to Preselect Stroke Patients for Enhanced ECG-Monitoring - Evaluation of Predictors of Paroxysmal Atrial Fibrillation in "Find-AFra…

2019

Background: Detecting concealed paroxysmal atrial fibrillation (pAF) is a major focus of the workup of ischemic-stroke-patients, but requires elaborate ECG-monitoring. We aimed to evaluate pre-specified predictors to determine stroke patients with an increased probability of underlying pAF. We applied cut-off-levels recently suggested by the German Stroke Society 1 . Methods: The Find-AF RANDOMISED -trial (NCT01855035) evaluated 3x10-day Holter-ECG vs. standard-care in 398 patients > 60 years with acute ischemic strokes. The primary endpoint was novel pAF after 6 months. 27 patients in the intervention arm (13.5 %) and 9 patients in the control arm (9.0 %) met the primary endpoint (p=0.…

Advanced and Specialized Nursingmedicine.medical_specialtymedicine.diagnostic_testStroke patientParoxysmal atrial fibrillationbusiness.industryAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseEcg monitoring03 medical and health sciences0302 clinical medicineInternal medicinemedicineCardiologycardiovascular diseasesNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessElectrocardiography030217 neurology & neurosurgeryStroke
researchProduct

Abstract WP200: Development and Validation of a Score to Detect Paroxysmal Atrial Fibrillation During Long-term Holter-monitoring After Acute Ischemi…

2018

Introduction: Atrial fibrillation remains one of the most common causes of ischemic stroke. The diagnosis of paroxysmal atrial fibrillation (pAF) frequently escapes routine diagnostic due to its intermittent and asymptomatic occurrence. Currently prolonged monitoring times (72h) are recommended, but did not find their way into everyday practice. Therefore an individual patient selection for prolonged ECG-monitoring might increase the diagnostic yield of pAF in a resource-saving and cost-effective manner. Methods: We used individual patient data from three prospective studies (n total =1556) which performed a prolonged Holter ECG-monitoring (at least 72 h) and centralized data evaluation af…

Advanced and Specialized Nursingmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryParoxysmal atrial fibrillationAtrial fibrillation030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineInternal medicineIschemic strokeCardiologymedicineNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessHolter monitoringStrokeElectrocardiographyAcute ischemic stroke030217 neurology & neurosurgeryStroke
researchProduct

Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Surve…

2006

Objectives: This study sought to investigate gender-related differences in patients with atrial fibrillation (AF) in Europe. Background: Gender-related differences may play a significant role in AF. Methods: We analyzed the data of 5,333 patients (42% female) enrolled in the Euro Heart Survey on Atrial Fibrillation. Results: Compared with men, the women were older, had a lower quality of life (QoL), had more comorbidities, more often had heart failure (HF) with preserved left ventricular systolic function (18% vs. 7%, p < 0.001), and less often had HF with systolic dysfunction (17% vs. 26%, p < 0.001). Among patients with typical AF symptoms (56% of women, 49% of men), there was no ge…

Aged 80 and overHeart FailureMaleHealth StatusHealth SurveyMiddle AgedHealth SurveysFollow-Up StudieHealth StatuEuropeStrokeSex FactorsTreatment OutcomeAtrial FibrillationQuality of LifeHumansFemaleHumanAgedFollow-Up StudiesJournal of the American College of Cardiology
researchProduct

Obesity and new-onset atrial fibrillation in acute myocardial infarction: a gender specific risk factor

2014

Aged 80 and overMaleSex Characteristicsmedicine.medical_specialtybusiness.industryMyocardial InfarctionSpecific riskAtrial fibrillationMiddle Agedmedicine.diseaseObesityNew onset atrial fibrillationRisk FactorsInternal medicineAtrial FibrillationmedicineCardiologyHumansFemaleObesityMyocardial infarctionCardiology and Cardiovascular MedicinebusinessAgedInternational Journal of Cardiology
researchProduct

Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction

2015

International audience; Background Atrial fibrillation (AF), whether silent or symptomatic, is a frequent and severe complication of acute myocardial infarction (AMI). Asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, is a risk factor for endothelial dysfunction. We addressed the relationship between ADMA plasma levels and AF occurrence in AMI.Methods 273 patients hospitalized for AMI were included. Continuous electrocardiographic monitoring (CEM) !48 hours was recorded and ADMA was measured by High Performance Liquid Chromatography on admission blood sample.Results The incidence of silent and symptomatic AF was 39(14%) and 29 (11%), respectively. AF patients were markedly o…

Aged 80 and overMalelcsh:RMyocardial Infarctionlcsh:MedicineMiddle AgedArginineRisk Assessment[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemElectrocardiographyOxidative StressLogistic Models[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk FactorsAtrial FibrillationMultivariate AnalysisHumansFemalelcsh:QEndotheliumlcsh:ScienceBiomarkersChromatography High Pressure LiquidResearch ArticleAged
researchProduct

Urea Cycle Metabolites and Atrial Fibrillation or Heart Failure Risk: Two Case-Control Studies in the PREDIMED Trial

2021

OBJECTIVES: To prospectively analyze the associations between urea cycle metabolites and incident atrial fibrillation (AF) or heart failure (HF), and to evaluate the effect of a Mediterranean diet (MD) intervention on such associations. METHODS: We designed two nested case-control studies within the PREDIMED trial, a randomized controlled trial aimed to evaluate the effect of two MD interventions, supplemented with either extra virgin olive oil (EVOO) or nuts, on cardiovascular disease (CVD). Fasting blood samples were collected at baseline and urea cycle metabolites (arginine, citrulline, and ornithine) and methylarginines (asymmetric dimethylarginine/symmetric dimethylarginine ratio (ADMA…

Aging and Chronic DiseaseNutrition and DieteticsArginineMediterranean dietDiet therapybusiness.industryMedicine (miscellaneous)Atrial fibrillationPharmacologyOrnithinemedicine.diseasechemistry.chemical_compoundchemistryHeart failureUrea cyclemedicineCitrullinebusinessFood ScienceCurrent Developments in Nutrition
researchProduct

The kinetic behavior of insulin fibrillation is determined by heterogeneous nucleation pathways

2005

When subjected to acidic conditions and high temperature, insulin is known to produce fibrils that display the common properties of disease amyloids. Thus, clarifying the mechanisms of insulin fibrillation can help the general understanding of amyloidal aggregation. Insulin fibrillation exhibits a very sharp time dependence, with a pronounced lag phase and subsequent explosive growth of amyloidal aggregates. Here we show that the initial stages of this process can be well described by exponential growth of the fibrillated proteins. This indicates that the process is mainly controlled by a secondary nucleation pathway.

AmyloidProtein DenaturationTime FactorsAmyloidmedicine.medical_treatmentKineticsNucleationmacromolecular substancesProtein aggregationFibrilBiochemistryExponential growthmedicineAnimalsInsulinMolecular BiologyFibrillationChemistryInsulinTemperatureHydrogen-Ion ConcentrationKineticsBiochemistryFor the RecordBiophysicsCattlemedicine.symptomProtein Science
researchProduct

Secondary nucleation and accessible surface in insulin amyloid fibril formation.

2008

At low pH insulin is highly prone to self-assembly into amyloid fibrils. The process has been proposed to be affected by the existence of secondary nucleation pathways, in which already formed fibrils are able to catalyze the formation of new fibrils. In this work, we studied the fibrillation process of human insulin in a wide range of protein concentrations. Thioflavin T fluorescence was used for its ability to selectively detect amyloid fibrils, by mechanisms that involve the interaction between the dye and the accessible surface of the fibrils. Our results show that the rate of fibrillation and the Thioflavin T fluorescence intensity saturate at high protein concentration and that, surpr…

AmyloidSurface Propertiesmedicine.medical_treatmentKineticsNucleationmacromolecular substancesProtein aggregationFibrilstochastic processchemistry.chemical_compoundMaterials ChemistrymedicineHumansInsulinBenzothiazolesPhysical and Theoretical ChemistryFibrillationChemistryInsulinFluorescenceSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Surfaces Coatings and FilmsCrystallographyKineticsThiazolesBiophysicsThioflavin TThioflavinmedicine.symptomProtein aggregationThe journal of physical chemistry. B
researchProduct